Thymosin Alpha 1 is a synthetic 28-amino-acid peptide fragment of prothymosin alpha that has been widely studied in immunology and cellular signaling research. Laboratory investigations have examined its relationship with T-cell maturation, dendritic cell activity, innate immune signaling, and toll-like receptor pathways.

NXTSTATE supplies Thymosin Alpha 1 peptide as a 5 mg lyophilized research compound with ≥98% purity, verified through HPLC analysis and supported by a third-party Certificate of Analysis (COA) for each lot.

Product Overview

Thymosin Alpha 1, also known as thymalfasin in clinical research literature, was originally identified as a peptide associated with thymic tissue and subsequently characterized as a fragment of prothymosin alpha. Its well-established research history has made it a commonly referenced compound in studies examining communication between innate and adaptive immune pathways.

The peptide consists of 28 amino acids and features N-terminal acetylation, a structural characteristic relevant to its biochemical properties. Research involving Thymosin Alpha 1 has covered cellular signaling, immune-cell function, receptor interactions, and molecular responses in different experimental models.

For researchers looking for a Thymosin A1 peptide vial for laboratory work, NXTSTATE provides the compound in a sealed, lyophilized format with batch-specific quality documentation.

Research Applications

Thymosin Alpha 1 has been investigated in several areas of laboratory research, including:

• T-cell research: Studies examining T-cell maturation, differentiation, and cellular function.
• Dendritic cell studies: Research into dendritic cell activation and antigen-related signaling.
• Innate immune signaling: Experimental work involving innate immune pathways and cellular responses.
• TLR pathway research: Investigations of interactions involving toll-like receptors, including TLR2 and TLR9.
• Cytokine signaling: Studies examining changes in cytokine expression and downstream cellular communication.
• NK-cell research: Laboratory investigations involving natural killer cell activity.
• Immune aging models: Research exploring changes in immune signaling associated with cellular aging.
• Vaccine and infection research: Experimental studies examining immune-response mechanisms in infection and vaccine-related models.

These applications describe areas of published research and should not be interpreted as therapeutic or medical claims.

Thymosin Alpha 1 Specifications

Quality & Batch Verification

NXTSTATE uses batch-level testing to document the identity and purity of its Thymosin Alpha 1 research material. Each lot is accompanied by a third-party Certificate of Analysis, allowing researchers to review the reported analytical results associated with the specific batch supplied.

HPLC testing is used to assess chromatographic purity, while mass spectrometry can support molecular identity confirmation. Researchers should always refer to the current lot-specific COA for the most relevant analytical information.

Handling and Storage

Thymosin Alpha 1 is supplied as a lyophilized research compound. The unopened material should be stored at -20°C according to the product specifications. After laboratory reconstitution, the material should be maintained at 2–8°C and handled according to the applicable laboratory protocol.

Avoid unnecessary temperature fluctuations and repeated freeze-thaw cycles. Researchers should determine appropriate preparation, handling, and stability procedures based on their experimental requirements and institutional protocols.

Why Researchers Use Thymosin A1 as a Research Compound

The long research history surrounding Thymosin Alpha 1 makes it useful for laboratory investigations involving peptide signaling and immune-cell communication. Its defined 28-amino-acid structure, documented interaction with immune-related pathways, and availability in a standardized lyophilized format make it suitable for controlled experimental research.

For laboratories sourcing a Thymosin A1 peptide supplier USA, batch documentation and analytical transparency are important considerations when comparing research materials. NXTSTATE provides lot-specific COA documentation alongside its research-grade peptide inventory.

Frequently Asked Questions

What is Thymosin Alpha 1?

Thymosin Alpha 1 is a 28-amino-acid peptide fragment of prothymosin alpha. It has been extensively investigated in laboratory research involving immune-cell signaling, T-cell biology, dendritic cells, and innate immune pathways.

What purity is the NXTSTATE Thymosin Alpha 1?

NXTSTATE Thymosin Alpha 1 is supplied at ≥98% purity, with analytical documentation provided through a third-party Certificate of Analysis.

What size is the Thymosin Alpha 1 vial?

The product is supplied as a 5 mg lyophilized peptide vial.

How should Thymosin Alpha 1 be stored?

The lyophilized material should be stored at -20°C for long-term storage. After reconstitution, the product specifications indicate storage at 2–8°C.

Is Thymosin Alpha 1 intended for human use?

No. This product is supplied strictly for research use only and is not intended for human or veterinary use, medical treatment, diagnosis, or consumption.

Research Use Only

Thymosin Alpha 1 from NXTSTATE is supplied exclusively as a laboratory research compound. It is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease.

Research use only. Not for human or veterinary use.